Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2025-12-25 @ 12:33 AM
NCT ID: NCT03213067
Eligibility Criteria: Inclusion Criteria: Mitochondrial Patients * Male and Females \>18 years at the time of screening * Patients must have proven genetic disease (confirmed by assessment of heteroplasmy in blood and urine samples) of the m.3243 A\>G mutation. * Capacity to provide informed consent taken before any study related activities. * Ability and willingness to adhere to the protocol, including all appointments. * Ability to read and converse in English. Healthy Controls * Male and Females \>18 years at the time of screening * Capacity to provide informed consent taken before any study related activities. * Ability and willingness to adhere to the protocol, including all appointments. * Ability to read and converse in English. Exclusion Criteria: * Previous history of contraindicated conditions including stroke, brain lesion(s) or tumour. * Abnormal clinical results as determined by physician. * Patient without capacity to provide informed consent. * Patient's unwillingness to adhere to the protocol, including all appointments. * Language barriers preventing patients from reading and conversing in English.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT03213067
Study Brief:
Protocol Section: NCT03213067